Immunology and Cancer Immunotherapy (ICI) The overall goal of the Immunology and Cancer Immunotherapy (ICI) Program is to unite the efforts of basic and clinical immunologists to explore the immune system's impact on cancer development and progression, to develop novel strategies that use immunity to treat cancer, and to conduct clinical trials to test novel therapeutics and approaches to improve patient outcomes and increase overall survival. There are twenty-one members from six different academic departments and two professional schools. The current focus and initiatives of the ICI scientists are centered on three themes: Immune regulation, Immune effector mechanisms, and Translational immunotherapy. The immunotherapy approaches are focused on adoptive T cell therapy, vaccination, and immune regulation blockade. While basic research is a key focus, many faculty members actively are involved in translational bench-to-bedside research. Other members are clinicians (hematologists, oncologists or oncologic surgeons) who actively are involved in clinical research and clinical trials. This program joins established and experienced clinical trialists with NCI-funded cancer immunologists to design, execute, and complete Dartmouth-initiated immunotherapy trials in renal cell carcinoma, melanoma, glioblastoma, colorectal carcinoma, multiple myeloma and hematopoietic stem cell transplantation. There are extensive collaborations between ICI members around common areas of interest in immunobiology and immunotherapy, as evidenced by joint publications and funded grants. Major contributions of the program to the mission of the NCCC have been the facilitation of new insights into the tumor microenvironment and how this is affected by leukocytes, the development of novel protein and cell therapies, the translation of Dartmouth investigator ideas into clinical trials, and the accrual of patients to these trials. NCCC has made substantial commitment to improving the depth and breadth of research and clinical translation of the ICI program through support of shared resources, financial awards for new pilot grants, and strategic recruitment of new investigators. More than 280 cancer-related articles have been published over the reporting period, with 46 (16%) appearing in high impact journals. Intra-programmatic publications (43=15%) involved 19 of our 22 members, and inter-programmatic publications (66=24%) involved 15 members. Total grant funding for the program currently is $6.4M, of which $5.5M is peer-reviewed and $2.2M is from NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-40
Application #
9616832
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shee, Kevin; Jiang, Amanda; Varn, Frederick S et al. (2018) Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J :fj201801241R
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Aging impacts CD103+ CD8+ T cell presence and induction by dendritic cells in the genital tract. Aging Cell 17:e12733
Shajani-Yi, Zahra; de Abreu, Francine B; Peterson, Jason D et al. (2018) Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia 20:256-262
Szczepiorkowski, Zbigniew M; Burnett, Christine A; Dumont, Larry J et al. (2018) Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems. Transfusion 58:943-950
Bossé, Yohan; Amos, Christopher I (2018) A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev 27:363-379
Pande, Mala; Joon, Aron; Brewster, Abenaa M et al. (2018) Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. PLoS One 13:e0196245
Smith, T Jarrod; Sondermann, Holger; O'Toole, George A (2018) Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces. ACS Synth Biol 7:2612-2617
Gorlova, Olga Y; Li, Yafang; Gorlov, Ivan et al. (2018) Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One 13:e0189498
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Cai, Yunliang; Wu, Shaoju; Zhao, Wei et al. (2018) Concussion classification via deep learning using whole-brain white matter fiber strains. PLoS One 13:e0197992

Showing the most recent 10 out of 1911 publications